agap2 ist eine 2005 gegründete europäische Ingenieur- und Betriebsberatungsgruppe, die sich auf Industriebereiche wie Pharma, Biotechnologie, Medizintechnik, Energie, Infrastruktur, Transport, Chemie und Informationstechnologie spezialisiert hat. Als Berater unterstützen Sie unsere Kunden bei der erfolgreichen Umsetzung ihrer
Salary Range:CHF154,700.00 - CHF287,300.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Welcome to where we thrive together! Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need as soon
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Desktop Support Specialist (DSS L1) - Dispatch On-Demand Work Model: Onsite Contract : B2B Freelance Engagement : Dispatch On-Demand / Ticket-Based Rate : EUR 40/hour | EUR 140/Half Day | EUR 260/Day Schedule : Monday-Friday |
Basel Hauptsitz/Siège | part time 60% | limited | immediately to | Allocator 60% (m/f/d) Special Everyday – that is our promise, and we base our service on it. With the values of team spirit, agility
Salary Range: CHF154,700.00 - CHF287,300.00 Location: Basel, Switzerland Job Description Summary #LI-Hybrid Welcome to where we thrive together! Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need
Job Description Summary #LI-Hybrid Salary Range: CHF154,700.00 - CHF287,300.00 Location: Basel, Switzerland Welcome to where we thrive together! Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need
1 out of 10 people are diagnosed with an autoimmune or autoinflammatory disease. This is why the Autoimmunity, Transplantation & Inflammation (ATI) Disease Area group at the Novartis Institutes for Biomedical Research (NIBR) is investing in